• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
KZA

KAZIA THERAPEUTICS LIMITED - Charts / Financials

0.00% ! 8.0¢
Currently unlisted.

Kazia Therapeutics Limited is an Australia-based oncology-focused drug development... Kazia Therapeutics Limited is an Australia-based oncology-focused drug development company. The Company is engaged in pharmaceutical research and development. The Company’s drug candidates are designed to treat diseases such as brain cancer, renal cancer, and liver cancer. The Company’s lead programs include paxalisib and EVT801. Paxalisib is a small molecule inhibitor of the PI3K / Akt / mTOR pathway, a central regulator of growth and cell division that is dysregulated in many types of cancer. Paxalisib is being developed for several forms of brain cancer. EVT801 is a small molecule inhibitor of VEGFR3. EVT801 is being developed in patients with advanced cancer. EVT801 targets angiogenesis, the formation of new blood vessels around a tumor.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

refresh Created with Sketch. REFRESH
Day chart unavailable
Last update - 11.05am 15/11/2023 (20 minute delay) ?
Day
Open 0.0¢   Day High 0.0¢   Day Low 0.0¢
Daily Volume 0
Bids   Sellers
Number Price Volume   Number Price Volume
0 0.0¢ 0   0 0.0¢ 0

Directors & Senior Management

Mr. Bryce Carmine Non-Executive Director
Mr. Iain Gladstone Ross Non-Executive Chairman of the Board
Dr. James B. Garner Chief Executive Officer, Executive Director
Dr. John E. Friend Chief Medical Officer
Dr. Justine R. Stehn Director - ATM Program
Ms. Karen Krumeich Chief Financial Officer
Ms. Kate Hill Interim Company Secretary
Lilischkis Ron Kimberley Clinical & Regulatory Affairs Manager
Mr. Peng K. Leong Chief Business Officer
Stephen Palmer Program Director - Degenerative Diseases
Mr. Steven Roy Stent Coffey Non-Executive Director

Data source: ADVFN

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
Capital Compass
AGE
AGE
ALLIGATOR ENERGY LIMITED
Dr Andrea Marsland-Smith, CEO
Dr Andrea Marsland-Smith
CEO
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.